Purple Biotech (PPBT) Free Cash Flow (2017 - 2026)
Purple Biotech (PPBT) reported Free Cash Flow of -$3.1 million for Q1 2026, down 57.79% year-over-year from -$7.4 million in Q1 2025, and down 57.79% on a QoQ basis from -$2.0 million in Q1 2025.
Purple Biotech (PPBT) has 2 years of Free Cash Flow data on file, last reported at -$3.1 million in Q1 2026.
- Quarterly Free Cash Flow fell 57.79% year-over-year to -$3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.1 million (down 157.79% YoY) and the FY2025 annual result came in at -$5.7 million, up 60.61% from the prior year.
- Free Cash Flow eased to -$3.1 million in Q1 2026 per PPBT's latest filing, from -$2.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$2.0 million in Q1 2025 and bottomed at -$3.1 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | -3.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.12 Mn |
| Mar 31, 2026 | -3.12 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Sep 30, 2025 | -1.07 Mn |
| Sep 30, 2025 | -1.07 Mn |
| Jun 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | -1.54 Mn |
| Mar 31, 2025 | -1.98 Mn |
| Mar 31, 2025 | -1.98 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Sep 30, 2024 | -3.30 Mn |
| Sep 30, 2024 | -3.30 Mn |
| Jun 30, 2024 | -3.98 Mn |
| Jun 30, 2024 | -3.98 Mn |
| Mar 31, 2024 | -5.08 Mn |
| Mar 31, 2024 | -5.08 Mn |
| Dec 31, 2023 | -4.99 Mn |
| Dec 31, 2023 | -4.99 Mn |
| Sep 30, 2023 | -3.66 Mn |
| Sep 30, 2023 | -3.66 Mn |
| Jun 30, 2023 | -5.22 Mn |
| Jun 30, 2023 | -5.22 Mn |
| Mar 31, 2023 | -6.06 Mn |
| Mar 31, 2023 | -6.06 Mn |
| Dec 31, 2022 | -4.27 Mn |
| Dec 31, 2022 | -4.27 Mn |
| Sep 30, 2022 | -3.62 Mn |
| Sep 30, 2022 | -3.62 Mn |
| Jun 30, 2022 | -3.69 Mn |
| Jun 30, 2022 | -3.69 Mn |
| Mar 31, 2022 | -5.19 Mn |
| Mar 31, 2022 | -5.19 Mn |
| Dec 31, 2021 | -3.54 Mn |
| Dec 31, 2021 | -3.54 Mn |
| Sep 30, 2021 | -2.90 Mn |
| Sep 30, 2021 | -2.90 Mn |
| Jun 30, 2021 | -5.02 Mn |
| Jun 30, 2021 | -5.02 Mn |
| Mar 31, 2021 | -3.30 Mn |
| Mar 31, 2021 | -3.30 Mn |
| Dec 31, 2020 | -6.57 Mn |
| Dec 31, 2020 | -6.57 Mn |
| Dec 31, 2019 | -3.31 Mn |
| Dec 31, 2019 | -3.31 Mn |
| Dec 31, 2018 | -4.99 Mn |
| Dec 31, 2018 | -4.99 Mn |
| Dec 31, 2017 | -3.93 Mn |
| Dec 31, 2017 | -3.93 Mn |